Global Polio (Poliomyelitis) Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Polio (Poliomyelitis) Vaccines Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Market Segment by Application
1.3.1 Global Polio (Poliomyelitis) Vaccines Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Research & Academic Laboratories
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Polio (Poliomyelitis) Vaccines Market Size (2017-2028)
2.1.1 Global Polio (Poliomyelitis) Vaccines Revenue (2017-2028)
2.1.2 Global Polio (Poliomyelitis) Vaccines Sales (2017-2028)
2.2 Global Polio (Poliomyelitis) Vaccines Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Polio (Poliomyelitis) Vaccines Sales by Regions (2017-2022)
2.2.2 Global Polio (Poliomyelitis) Vaccines Revenue by Regions (2017-2022)
2.3 Global Polio (Poliomyelitis) Vaccines Market Size Forecast by Region
2.3.1 Global Polio (Poliomyelitis) Vaccines Sales Forecast by Region (2023-2028)
2.3.2 Global Polio (Poliomyelitis) Vaccines Revenue Forecast by Region (2023-2028)
2.4 Global Top Polio (Poliomyelitis) Vaccines Regions (Countries) Ranking by Market Size
2.5 Polio (Poliomyelitis) Vaccines Market Dynamics
2.5.1 Polio (Poliomyelitis) Vaccines Market Trends
2.5.2 Polio (Poliomyelitis) Vaccines Market Drivers
2.5.3 Polio (Poliomyelitis) Vaccines Market Challenges
2.5.4 Polio (Poliomyelitis) Vaccines Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Polio (Poliomyelitis) Vaccines Manufacturers by Sales (2017-2022)
3.1.1 Global Polio (Poliomyelitis) Vaccines Sales by Manufacturers (2017-2022)
3.1.2 Global Polio (Poliomyelitis) Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Polio (Poliomyelitis) Vaccines Sales in 2021
3.2 Global Top Manufacturers Polio (Poliomyelitis) Vaccines by Revenue
3.2.1 Global Polio (Poliomyelitis) Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Top Polio (Poliomyelitis) Vaccines Manufacturers Covered: Ranking by Revenue
3.2.3 Global Polio (Poliomyelitis) Vaccines Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Polio (Poliomyelitis) Vaccines Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Polio (Poliomyelitis) Vaccines as of 2021)
3.4 Global Polio (Poliomyelitis) Vaccines Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Polio (Poliomyelitis) Vaccines Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Polio (Poliomyelitis) Vaccines Market
3.7 Key Manufacturers Polio (Poliomyelitis) Vaccines Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Polio (Poliomyelitis) Vaccines Market Size by Type
4.1 Global Polio (Poliomyelitis) Vaccines Historic Market Review by Type (2017-2022)
4.1.1 Global Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2017-2022)
4.1.2 Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Type (2017-2022)
4.1.3 Polio (Poliomyelitis) Vaccines Price by Type (2017-2022)
4.2 Global Polio (Poliomyelitis) Vaccines Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Polio (Poliomyelitis) Vaccines Sales Forecast by Type (2023-2028)
4.2.2 Global Polio (Poliomyelitis) Vaccines Revenue Forecast by Type (2023-2028)
4.2.3 Polio (Poliomyelitis) Vaccines Price Forecast by Type (2023-2028)
5 Global Polio (Poliomyelitis) Vaccines Market Size by Application
5.1 Global Polio (Poliomyelitis) Vaccines Historic Market Review by Application (2017-2022)
5.1.1 Global Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2017-2022)
5.1.2 Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Application (2017-2022)
5.1.3 Polio (Poliomyelitis) Vaccines Price by Application (2017-2022)
5.2 Global Polio (Poliomyelitis) Vaccines Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Polio (Poliomyelitis) Vaccines Sales Forecast by Application (2023-2028)
5.2.2 Global Polio (Poliomyelitis) Vaccines Revenue Forecast by Application (2023-2028)
5.2.3 Polio (Poliomyelitis) Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Polio (Poliomyelitis) Vaccines Sales Breakdown by Company
6.1.1 North America Polio (Poliomyelitis) Vaccines Sales by Company (2017-2022)
6.1.2 North America Polio (Poliomyelitis) Vaccines Revenue by Company (2017-2022)
6.2 North America Polio (Poliomyelitis) Vaccines Market Size by Type
6.2.1 North America Polio (Poliomyelitis) Vaccines Sales by Type (2017-2028)
6.2.2 North America Polio (Poliomyelitis) Vaccines Revenue by Type (2017-2028)
6.3 North America Polio (Poliomyelitis) Vaccines Market Size by Application
6.3.1 North America Polio (Poliomyelitis) Vaccines Sales by Application (2017-2028)
6.3.2 North America Polio (Poliomyelitis) Vaccines Revenue by Application (2017-2028)
6.4 North America Polio (Poliomyelitis) Vaccines Market Size by Country
6.4.1 North America Polio (Poliomyelitis) Vaccines Sales by Country (2017-2028)
6.4.2 North America Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Polio (Poliomyelitis) Vaccines Sales Breakdown by Company
7.1.1 Europe Polio (Poliomyelitis) Vaccines Sales by Company (2017-2022)
7.1.2 Europe Polio (Poliomyelitis) Vaccines Revenue by Company (2017-2022)
7.2 Europe Polio (Poliomyelitis) Vaccines Market Size by Type
7.2.1 Europe Polio (Poliomyelitis) Vaccines Sales by Type (2017-2028)
7.2.2 Europe Polio (Poliomyelitis) Vaccines Revenue by Type (2017-2028)
7.3 Europe Polio (Poliomyelitis) Vaccines Market Size by Application
7.3.1 Europe Polio (Poliomyelitis) Vaccines Sales by Application (2017-2028)
7.3.2 Europe Polio (Poliomyelitis) Vaccines Revenue by Application (2017-2028)
7.4 Europe Polio (Poliomyelitis) Vaccines Market Size by Country
7.4.1 Europe Polio (Poliomyelitis) Vaccines Sales by Country (2017-2028)
7.4.2 Europe Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Polio (Poliomyelitis) Vaccines Sales Breakdown by Company
8.1.1 Asia Pacific Polio (Poliomyelitis) Vaccines Sales by Company (2017-2022)
8.1.2 Asia Pacific Polio (Poliomyelitis) Vaccines Revenue by Company (2017-2022)
8.2 Asia Pacific Polio (Poliomyelitis) Vaccines Market Size by Type
8.2.1 Asia Pacific Polio (Poliomyelitis) Vaccines Sales by Type (2017-2028)
8.2.2 Asia Pacific Polio (Poliomyelitis) Vaccines Revenue by Type (2017-2028)
8.3 Asia Pacific Polio (Poliomyelitis) Vaccines Market Size by Application
8.3.1 Asia Pacific Polio (Poliomyelitis) Vaccines Sales by Application (2017-2028)
8.3.2 Asia Pacific Polio (Poliomyelitis) Vaccines Revenue by Application (2017-2028)
8.4 Asia Pacific Polio (Poliomyelitis) Vaccines Market Size by Region
8.4.1 Asia Pacific Polio (Poliomyelitis) Vaccines Sales by Region
8.4.2 Asia Pacific Polio (Poliomyelitis) Vaccines Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Polio (Poliomyelitis) Vaccines Sales Breakdown by Company
9.1.1 Latin America Polio (Poliomyelitis) Vaccines Sales by Company (2017-2022)
9.1.2 Latin America Polio (Poliomyelitis) Vaccines Revenue by Company (2017-2022)
9.2 Latin America Polio (Poliomyelitis) Vaccines Market Size by Type
9.2.1 Latin America Polio (Poliomyelitis) Vaccines Sales by Type (2017-2028)
9.2.2 Latin America Polio (Poliomyelitis) Vaccines Revenue by Type (2017-2028)
9.3 Latin America Polio (Poliomyelitis) Vaccines Market Size by Application
9.3.1 Latin America Polio (Poliomyelitis) Vaccines Sales by Application (2017-2028)
9.3.2 Latin America Polio (Poliomyelitis) Vaccines Revenue by Application (2017-2028)
9.4 Latin America Polio (Poliomyelitis) Vaccines Market Size by Country
9.4.1 Latin America Polio (Poliomyelitis) Vaccines Sales by Country (2017-2028)
9.4.2 Latin America Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Polio (Poliomyelitis) Vaccines Sales Breakdown by Company
10.1.1 Middle East and Africa Polio (Poliomyelitis) Vaccines Sales by Company (2017-2022)
10.1.2 Middle East and Africa Polio (Poliomyelitis) Vaccines Revenue by Company (2017-2022)
10.2 Middle East and Africa Polio (Poliomyelitis) Vaccines Market Size by Type
10.2.1 Middle East and Africa Polio (Poliomyelitis) Vaccines Sales by Type (2017-2028)
10.2.2 Middle East and Africa Polio (Poliomyelitis) Vaccines Revenue by Type (2017-2028)
10.3 Middle East and Africa Polio (Poliomyelitis) Vaccines Market Size by Application
10.3.1 Middle East and Africa Polio (Poliomyelitis) Vaccines Sales by Application (2017-2028)
10.3.2 Middle East and Africa Polio (Poliomyelitis) Vaccines Revenue by Application (2017-2028)
10.4 Middle East and Africa Polio (Poliomyelitis) Vaccines Market Size by Country
10.4.1 Middle East and Africa Polio (Poliomyelitis) Vaccines Sales by Country (2017-2028)
10.4.2 Middle East and Africa Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Polio (Poliomyelitis) Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Sanofi Polio (Poliomyelitis) Vaccines Products and Services
11.1.5 Sanofi Polio (Poliomyelitis) Vaccines SWOT Analysis
11.1.6 Sanofi Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Polio (Poliomyelitis) Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 GSK Polio (Poliomyelitis) Vaccines Products and Services
11.2.5 GSK Polio (Poliomyelitis) Vaccines SWOT Analysis
11.2.6 GSK Recent Developments
11.3 Bibcol
11.3.1 Bibcol Corporation Information
11.3.2 Bibcol Overview
11.3.3 Bibcol Polio (Poliomyelitis) Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Bibcol Polio (Poliomyelitis) Vaccines Products and Services
11.3.5 Bibcol Polio (Poliomyelitis) Vaccines SWOT Analysis
11.3.6 Bibcol Recent Developments
11.4 Serum Institute
11.4.1 Serum Institute Corporation Information
11.4.2 Serum Institute Overview
11.4.3 Serum Institute Polio (Poliomyelitis) Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Serum Institute Polio (Poliomyelitis) Vaccines Products and Services
11.4.5 Serum Institute Polio (Poliomyelitis) Vaccines SWOT Analysis
11.4.6 Serum Institute Recent Developments
11.5 Tiantan Biological
11.5.1 Tiantan Biological Corporation Information
11.5.2 Tiantan Biological Overview
11.5.3 Tiantan Biological Polio (Poliomyelitis) Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Tiantan Biological Polio (Poliomyelitis) Vaccines Products and Services
11.5.5 Tiantan Biological Polio (Poliomyelitis) Vaccines SWOT Analysis
11.5.6 Tiantan Biological Recent Developments
11.6 IMBCA
11.6.1 IMBCA Corporation Information
11.6.2 IMBCA Overview
11.6.3 IMBCA Polio (Poliomyelitis) Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 IMBCA Polio (Poliomyelitis) Vaccines Products and Services
11.6.5 IMBCA Polio (Poliomyelitis) Vaccines SWOT Analysis
11.6.6 IMBCA Recent Developments
11.7 Panacea Biotec Ltd
11.7.1 Panacea Biotec Ltd Corporation Information
11.7.2 Panacea Biotec Ltd Overview
11.7.3 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Products and Services
11.7.5 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines SWOT Analysis
11.7.6 Panacea Biotec Ltd Recent Developments
11.8 Bio-Med
11.8.1 Bio-Med Corporation Information
11.8.2 Bio-Med Overview
11.8.3 Bio-Med Polio (Poliomyelitis) Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Bio-Med Polio (Poliomyelitis) Vaccines Products and Services
11.8.5 Bio-Med Polio (Poliomyelitis) Vaccines SWOT Analysis
11.8.6 Bio-Med Recent Developments
11.9 Halfkin Bio-Pharmaceuticals
11.9.1 Halfkin Bio-Pharmaceuticals Corporation Information
11.9.2 Halfkin Bio-Pharmaceuticals Overview
11.9.3 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Products and Services
11.9.5 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines SWOT Analysis
11.9.6 Halfkin Bio-Pharmaceuticals Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Polio (Poliomyelitis) Vaccines Value Chain Analysis
12.2 Polio (Poliomyelitis) Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Polio (Poliomyelitis) Vaccines Production Mode & Process
12.4 Polio (Poliomyelitis) Vaccines Sales and Marketing
12.4.1 Polio (Poliomyelitis) Vaccines Sales Channels
12.4.2 Polio (Poliomyelitis) Vaccines Distributors
12.5 Polio (Poliomyelitis) Vaccines Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of TablesTable 1. Global Polio (Poliomyelitis) Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Inactivated Polio Vaccine (IPV)
Table 3. Major Manufacturers of Oral Polio Vaccine (OPV)
Table 4. Global Polio (Poliomyelitis) Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Polio (Poliomyelitis) Vaccines Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Polio (Poliomyelitis) Vaccines Sales by Region (2017-2022) & (K Units)
Table 7. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Region (2017-2022)
Table 8. Global Polio (Poliomyelitis) Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Region (2017-2022)
Table 10. Global Polio (Poliomyelitis) Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 11. Global Polio (Poliomyelitis) Vaccines Sales Market Share Forecast by Region (2023-2028)
Table 12. Global Polio (Poliomyelitis) Vaccines Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 13. Global Polio (Poliomyelitis) Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 14. Top Polio (Poliomyelitis) Vaccines Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 15. Polio (Poliomyelitis) Vaccines Market Trends
Table 16. Polio (Poliomyelitis) Vaccines Market Drivers
Table 17. Polio (Poliomyelitis) Vaccines Market Challenges
Table 18. Polio (Poliomyelitis) Vaccines Market Restraints
Table 19. Global Polio (Poliomyelitis) Vaccines Sales by Manufacturers (2017-2022) & (K Units)
Table 20. Global Polio (Poliomyelitis) Vaccines Sales Share by Manufacturers (2017-2022)
Table 21. Global Polio (Poliomyelitis) Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Ranking of Global Top Polio (Poliomyelitis) Vaccines Manufacturers by Revenue (US$ Million) in 2021
Table 23. Polio (Poliomyelitis) Vaccines Revenue Share by Manufacturers (2017-2022)
Table 24. Global Polio (Poliomyelitis) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Polio (Poliomyelitis) Vaccines as of 2021)
Table 26. Key Manufacturers Polio (Poliomyelitis) Vaccines Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 27. Key Manufacturers Polio (Poliomyelitis) Vaccines Plants/Factories Distribution
Table 28. Key Manufacturers Polio (Poliomyelitis) Vaccines Area Served
Table 29. Date of Key Manufacturers Enter into Polio (Poliomyelitis) Vaccines Market
Table 30. Key Manufacturers Polio (Poliomyelitis) Vaccines Product Type
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Polio (Poliomyelitis) Vaccines Sales (K Units) by Type (2017-2022)
Table 33. Global Polio (Poliomyelitis) Vaccines Sales Share by Type (2017-2022)
Table 34. Global Polio (Poliomyelitis) Vaccines Revenue (US$ Million) Market Share by Type (2017-2022)
Table 35. Global Polio (Poliomyelitis) Vaccines Price (K Units) by Type (2017-2022)
Table 36. Global Polio (Poliomyelitis) Vaccines Sales (K Units) by Type (2023-2028)
Table 37. Global Polio (Poliomyelitis) Vaccines Sales Share by Type (2023-2028)
Table 38. Global Polio (Poliomyelitis) Vaccines Revenue (US$ Million) Market Share by Type (2023-2028)
Table 39. Global Polio (Poliomyelitis) Vaccines Revenue Share by Type (2023-2028)
Table 40. Global Polio (Poliomyelitis) Vaccines Price (K Units) by Type (2023-2028)
Table 41. Global Polio (Poliomyelitis) Vaccines Sales (K Units) by Application (2017-2022)
Table 42. Global Polio (Poliomyelitis) Vaccines Sales Share by Application (2017-2022)
Table 43. Global Polio (Poliomyelitis) Vaccines Revenue (US$ Million) Market Share by Application (2017-2022)
Table 44. Global Polio (Poliomyelitis) Vaccines Price (K Units) by Application (2017-2022)
Table 45. Global Polio (Poliomyelitis) Vaccines Sales (K Units) by Application (2023-2028)
Table 46. Global Polio (Poliomyelitis) Vaccines Sales Share by Application (2023-2028)
Table 47. Global Polio (Poliomyelitis) Vaccines Revenue (US$ Million) Market Share by Application (2023-2028)
Table 48. Global Polio (Poliomyelitis) Vaccines Revenue Share by Application (2023-2028)
Table 49. Global Polio (Poliomyelitis) Vaccines Price (K Units) by Application (2023-2028)
Table 50. North America Polio (Poliomyelitis) Vaccines Sales by Company (2017-2022) & (K Units)
Table 51. North America Polio (Poliomyelitis) Vaccines Sales Market Share by Company (2017-2022)
Table 52. North America Polio (Poliomyelitis) Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 53. North America Polio (Poliomyelitis) Vaccines Revenue Market Share by Company (2017-2022)
Table 54. North America Polio (Poliomyelitis) Vaccines Sales by Type (2017-2022) & (K Units)
Table 55. North America Polio (Poliomyelitis) Vaccines Sales by Type (2023-2028) & (K Units)
Table 56. North America Polio (Poliomyelitis) Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 57. North America Polio (Poliomyelitis) Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 58. North America Polio (Poliomyelitis) Vaccines Sales by Application (2017-2022) & (K Units)
Table 59. North America Polio (Poliomyelitis) Vaccines Sales by Application (2023-2028) & (K Units)
Table 60. North America Polio (Poliomyelitis) Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 61. North America Polio (Poliomyelitis) Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 62. North America Polio (Poliomyelitis) Vaccines Sales by Country (2017-2022) & (K Units)
Table 63. North America Polio (Poliomyelitis) Vaccines Sales by Country (2023-2028) & (K Units)
Table 64. North America Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 65. North America Polio (Poliomyelitis) Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 66. Europe Polio (Poliomyelitis) Vaccines Sales by Company (2017-2022) & (K Units)
Table 67. Europe Polio (Poliomyelitis) Vaccines Sales Market Share by Company (2017-2022)
Table 68. Europe Polio (Poliomyelitis) Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 69. Europe Polio (Poliomyelitis) Vaccines Revenue Market Share by Company (2017-2022)
Table 70. Europe Polio (Poliomyelitis) Vaccines Sales by Type (2017-2022) & (K Units)
Table 71. Europe Polio (Poliomyelitis) Vaccines Sales by Type (2023-2028) & (K Units)
Table 72. Europe Polio (Poliomyelitis) Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 73. Europe Polio (Poliomyelitis) Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 74. Europe Polio (Poliomyelitis) Vaccines Sales by Application (2017-2022) & (K Units)
Table 75. Europe Polio (Poliomyelitis) Vaccines Sales by Application (2023-2028) & (K Units)
Table 76. Europe Polio (Poliomyelitis) Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 77. Europe Polio (Poliomyelitis) Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 78. Europe Polio (Poliomyelitis) Vaccines Sales by Country (2017-2022) & (K Units)
Table 79. Europe Polio (Poliomyelitis) Vaccines Sales by Country (2023-2028) & (K Units)
Table 80. Europe Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 81. Europe Polio (Poliomyelitis) Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 82. Asia Pacific Polio (Poliomyelitis) Vaccines Sales by Company (2017-2022) & (K Units)
Table 83. Asia Pacific Polio (Poliomyelitis) Vaccines Sales Market Share by Company (2017-2022)
Table 84. Asia Pacific Polio (Poliomyelitis) Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 85. Asia Pacific Polio (Poliomyelitis) Vaccines Revenue Market Share by Company (2017-2022)
Table 86. Asia Pacific Polio (Poliomyelitis) Vaccines Sales by Type (2017-2022) & (K Units)
Table 87. Asia Pacific Polio (Poliomyelitis) Vaccines Sales by Type (2023-2028) & (K Units)
Table 88. Asia Pacific Polio (Poliomyelitis) Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 89. Asia Pacific Polio (Poliomyelitis) Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 90. Asia Pacific Polio (Poliomyelitis) Vaccines Sales by Application (2017-2022) & (K Units)
Table 91. Asia Pacific Polio (Poliomyelitis) Vaccines Sales by Application (2023-2028) & (K Units)
Table 92. Asia Pacific Polio (Poliomyelitis) Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 93. Asia Pacific Polio (Poliomyelitis) Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 94. Asia Pacific Polio (Poliomyelitis) Vaccines Sales by Region (2017-2022) & (K Units)
Table 95. Asia Pacific Polio (Poliomyelitis) Vaccines Sales by Region (2023-2028) & (K Units)
Table 96. Asia Pacific Polio (Poliomyelitis) Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 97. Asia Pacific Polio (Poliomyelitis) Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 98. Latin America Polio (Poliomyelitis) Vaccines Sales by Company (2017-2022) & (K Units)
Table 99. Latin America Polio (Poliomyelitis) Vaccines Sales Market Share by Company (2017-2022)
Table 100. Latin America Polio (Poliomyelitis) Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 101. Latin America Polio (Poliomyelitis) Vaccines Revenue Market Share by Company (2017-2022)
Table 102. Latin America Polio (Poliomyelitis) Vaccines Sales by Type (2017-2022) & (K Units)
Table 103. Latin America Polio (Poliomyelitis) Vaccines Sales by Type (2023-2028) & (K Units)
Table 104. Latin America Polio (Poliomyelitis) Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 105. Latin America Polio (Poliomyelitis) Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 106. Latin America Polio (Poliomyelitis) Vaccines Sales by Application (2017-2022) & (K Units)
Table 107. Latin America Polio (Poliomyelitis) Vaccines Sales by Application (2023-2028) & (K Units)
Table 108. Latin America Polio (Poliomyelitis) Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 109. Latin America Polio (Poliomyelitis) Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 110. Latin America Polio (Poliomyelitis) Vaccines Sales by Country (2017-2022) & (K Units)
Table 111. Latin America Polio (Poliomyelitis) Vaccines Sales by Country (2023-2028) & (K Units)
Table 112. Latin America Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 113. Latin America Polio (Poliomyelitis) Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 114. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales by Company (2017-2022) & (K Units)
Table 115. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales Market Share by Company (2017-2022)
Table 116. Middle East and Africa Polio (Poliomyelitis) Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 117. Middle East and Africa Polio (Poliomyelitis) Vaccines Revenue Market Share by Company (2017-2022)
Table 118. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales by Type (2017-2022) & (K Units)
Table 119. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales by Type (2023-2028) & (K Units)
Table 120. Middle East and Africa Polio (Poliomyelitis) Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 121. Middle East and Africa Polio (Poliomyelitis) Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 122. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales by Application (2017-2022) & (K Units)
Table 123. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales by Application (2023-2028) & (K Units)
Table 124. Middle East and Africa Polio (Poliomyelitis) Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Polio (Poliomyelitis) Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 126. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales by Country (2017-2022) & (K Units)
Table 127. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales by Country (2023-2028) & (K Units)
Table 128. Middle East and Africa Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 129. Middle East and Africa Polio (Poliomyelitis) Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 130. Sanofi Corporation Information
Table 131. Sanofi Description and Overview
Table 132. Sanofi Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 133. Sanofi Polio (Poliomyelitis) Vaccines Product and Services
Table 134. Sanofi Polio (Poliomyelitis) Vaccines SWOT Analysis
Table 135. Sanofi Recent Developments
Table 136. GSK Corporation Information
Table 137. GSK Description and Overview
Table 138. GSK Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 139. GSK Polio (Poliomyelitis) Vaccines Product and Services
Table 140. GSK Polio (Poliomyelitis) Vaccines SWOT Analysis
Table 141. GSK Recent Developments
Table 142. Bibcol Corporation Information
Table 143. Bibcol Description and Overview
Table 144. Bibcol Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 145. Bibcol Polio (Poliomyelitis) Vaccines Product and Services
Table 146. Bibcol Polio (Poliomyelitis) Vaccines SWOT Analysis
Table 147. Bibcol Recent Developments
Table 148. Serum Institute Corporation Information
Table 149. Serum Institute Description and Overview
Table 150. Serum Institute Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 151. Serum Institute Polio (Poliomyelitis) Vaccines Product and Services
Table 152. Serum Institute Polio (Poliomyelitis) Vaccines SWOT Analysis
Table 153. Serum Institute Recent Developments
Table 154. Tiantan Biological Corporation Information
Table 155. Tiantan Biological Description and Overview
Table 156. Tiantan Biological Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 157. Tiantan Biological Polio (Poliomyelitis) Vaccines Product and Services
Table 158. Tiantan Biological Polio (Poliomyelitis) Vaccines SWOT Analysis
Table 159. Tiantan Biological Recent Developments
Table 160. IMBCA Corporation Information
Table 161. IMBCA Description and Overview
Table 162. IMBCA Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 163. IMBCA Polio (Poliomyelitis) Vaccines Product and Services
Table 164. IMBCA Polio (Poliomyelitis) Vaccines SWOT Analysis
Table 165. IMBCA Recent Developments
Table 166. Panacea Biotec Ltd Corporation Information
Table 167. Panacea Biotec Ltd Description and Overview
Table 168. Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 169. Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Product and Services
Table 170. Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines SWOT Analysis
Table 171. Panacea Biotec Ltd Recent Developments
Table 172. Bio-Med Corporation Information
Table 173. Bio-Med Description and Overview
Table 174. Bio-Med Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 175. Bio-Med Polio (Poliomyelitis) Vaccines Product and Services
Table 176. Bio-Med Polio (Poliomyelitis) Vaccines SWOT Analysis
Table 177. Bio-Med Recent Developments
Table 178. Halfkin Bio-Pharmaceuticals Corporation Information
Table 179. Halfkin Bio-Pharmaceuticals Description and Overview
Table 180. Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 181. Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Product and Services
Table 182. Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines SWOT Analysis
Table 183. Halfkin Bio-Pharmaceuticals Recent Development